-
平臺(tái)編號(hào)：bio-110390
-
國(guó)際編號(hào)：ATCC BAA-2779
-
拉丁屬名： Escherichia coli
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
Escherichia coli *
Escherichia coli (Migula) Castellani and Chalmers 拉丁名
(ATCC? BAA-2779?) 統(tǒng)一編號(hào)
Reports Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As Escherichia coli
Verified By Whole-genome Sequencing
Classification Enterobacteriaceae, Escherichia
Strain Designations 別名 1136922
Application Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation 用途 Urine
Isolation Date 2014
Geographic Source Israel
Biosafety Level 生物安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 frozen
Storage Conditions 保藏條件 -80°C or colder
Preceptrol? no
Annotated Genes AAC(3)-IIa
AAC(6')-Ib-cr
acrA
acrB
acrD
acrE
acrF
APH(3'')-Ib
APH(6)-Id
baeR
catB3
CMY-2
CMY-47
emrB
KPC-2
macA
macB
marA
mdtB
mdtC
mdtF
msbA
OXA-1
qnrB20
TEM-1
tet(G)
tolC
Type Strain no
MIC Range Susceptible
Amikacin: ≤16 μg/mL
Fosfomycin: ≤64 μg/mL
Intermediate
Doripenem: 2 μg/mL
Imipenem: 2 μg/mL
Resistant
Amoxicillin-clavulanate: ≥32/16 μg/mL
Aztreonam: ≥16 μg/mL
Cefepime: ≥16 μg/mL
Ceftazidime: ≥16 μg/mL
Ceftriaxone: ≥4 μg/mL
Ciprofloxacin: ≥4 μg/mL
Levofloxacin: ≥8 μg/mL
Meropenem: ≥4 μg/mL
Piperacillin-tazobactam: ≥128/4 μg/mL
Tetracycline: ≥16 μg/mL
Trimethoprim-sulfamethoxazole: ≥4/76 μg/mL
Comments 注釋 This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.
Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition.
Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium 培養(yǎng)基 ATCC? Medium 18: Trypticase Soy Agar/Broth
Growth Conditions 生長(zhǎng)條件 Temperature: 37°C
Atmosphere 需氧條件 : Aerobic
Name of Depositor 寄存者 International Health Management Associates (IHMA), Inc.
Special Collection Global Priority Superbugs
Chain of Custody ATCC <-- International Health Management Associates (IHMA), Inc.
Geographic Source Israel
Patient Age 83
Patient Gender Male
References 參考文獻(xiàn)
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.
(ATCC? BAA-2779?) 統(tǒng)一編號(hào)
Reports Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As Escherichia coli
Verified By Whole-genome Sequencing
Classification Enterobacteriaceae, Escherichia
Strain Designations 別名 1136922
Application Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation 用途 Urine
Isolation Date 2014
Geographic Source Israel
Biosafety Level 生物安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 frozen
Storage Conditions 保藏條件 -80°C or colder
Preceptrol? no
Annotated Genes AAC(3)-IIa
AAC(6')-Ib-cr
acrA
acrB
acrD
acrE
acrF
APH(3'')-Ib
APH(6)-Id
baeR
catB3
CMY-2
CMY-47
emrB
KPC-2
macA
macB
marA
mdtB
mdtC
mdtF
msbA
OXA-1
qnrB20
TEM-1
tet(G)
tolC
Type Strain no
MIC Range Susceptible
Amikacin: ≤16 μg/mL
Fosfomycin: ≤64 μg/mL
Intermediate
Doripenem: 2 μg/mL
Imipenem: 2 μg/mL
Resistant
Amoxicillin-clavulanate: ≥32/16 μg/mL
Aztreonam: ≥16 μg/mL
Cefepime: ≥16 μg/mL
Ceftazidime: ≥16 μg/mL
Ceftriaxone: ≥4 μg/mL
Ciprofloxacin: ≥4 μg/mL
Levofloxacin: ≥8 μg/mL
Meropenem: ≥4 μg/mL
Piperacillin-tazobactam: ≥128/4 μg/mL
Tetracycline: ≥16 μg/mL
Trimethoprim-sulfamethoxazole: ≥4/76 μg/mL
Comments 注釋 This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.
Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition.
Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium 培養(yǎng)基 ATCC? Medium 18: Trypticase Soy Agar/Broth
Growth Conditions 生長(zhǎng)條件 Temperature: 37°C
Atmosphere 需氧條件 : Aerobic
Name of Depositor 寄存者 International Health Management Associates (IHMA), Inc.
Special Collection Global Priority Superbugs
Chain of Custody ATCC <-- International Health Management Associates (IHMA), Inc.
Geographic Source Israel
Patient Age 83
Patient Gender Male
References 參考文獻(xiàn)
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.
